<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.hcplive.com/view/q-a-how-lifelong-burdens-shaped-childhood-eczema-delphine-kerob-md</loc><lastmod>2026-06-03T23:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T23:00:00Z</news:publication_date>
        <news:title><![CDATA[Q&A: How Lifelong Burdens Are Shaped by Childhood Eczema, With Delphine Kerob, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/moving-the-needle-in-medicine-mentorship-medicine-and-the-making-of-an-innovator-with-jim-januzzi-md</loc><lastmod>2026-06-03T21:30:00Z</lastmod><news:news><news:publication_date>2026-06-03T21:30:00Z</news:publication_date>
        <news:title><![CDATA[Moving the Needle in Medicine: Mentorship, Medicine, and the Making of an Innovator, With Jim Januzzi, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/fda-expansion-linaclotide-children-2-5-years-functional-constipation</loc><lastmod>2026-06-03T20:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T20:00:00Z</news:publication_date>
        <news:title><![CDATA[FDA Expansion of Linaclotide for Children 2-5 Years With Functional Constipation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/6-gastroenterology-headlines-you-missed-in-may-2026</loc><lastmod>2026-06-03T19:53:49.225Z</lastmod><news:news><news:publication_date>2026-06-03T19:53:49.225Z</news:publication_date>
        <news:title><![CDATA[6 Gastroenterology Headlines You Missed in May 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/ats-2026-pulmonology-ad109-ralinepag-alis-itepekimab</loc><lastmod>2026-06-03T17:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T17:00:00Z</news:publication_date>
        <news:title><![CDATA[HCPLive Five: Pulmonology Updates at ATS 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/7-endocrinology-headlines-you-missed-in-may-2026</loc><lastmod>2026-06-03T16:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T16:00:00Z</news:publication_date>
        <news:title><![CDATA[7 Endocrinology Headlines You Missed in May 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/4-nephrology-headlines-may-2026</loc><lastmod>2026-06-03T15:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T15:00:00Z</news:publication_date>
        <news:title><![CDATA[4 Nephrology Headlines You Missed in May 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/7-dermatology-headlines-you-missed-may-2026</loc><lastmod>2026-06-03T14:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T14:00:00Z</news:publication_date>
        <news:title><![CDATA[7 Dermatology Headlines You Missed in May 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/nipocalimab-reduces-disease-activity-in-moderate-to-severe-sle-in-phase-2-trial</loc><lastmod>2026-06-03T13:43:36.176Z</lastmod><news:news><news:publication_date>2026-06-03T13:43:36.176Z</news:publication_date>
        <news:title><![CDATA[Nipocalimab Reduces Disease Activity in Moderate-to-Severe SLE in Phase 2 Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/expert-consensus-offers-age-specific-guidance-for-genital-psoriasis-care</loc><lastmod>2026-06-03T12:36:36.803Z</lastmod><news:news><news:publication_date>2026-06-03T12:36:36.803Z</news:publication_date>
        <news:title><![CDATA[Expert Consensus Offers Age-Specific Guidance for Genital Psoriasis Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/ecp-linked-improved-survival-refractory-bronchiolitis-obliterans-syndrome</loc><lastmod>2026-06-03T12:00:00Z</lastmod><news:news><news:publication_date>2026-06-03T12:00:00Z</news:publication_date>
        <news:title><![CDATA[ECP Linked to Improved Survival in Refractory Bronchiolitis Obliterans Syndrome]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/10-cardiology-headlines-you-missed-in-may-2026</loc><lastmod>2026-06-02T23:00:00Z</lastmod><news:news><news:publication_date>2026-06-02T23:00:00Z</news:publication_date>
        <news:title><![CDATA[10 Cardiology Headlines You Missed in May 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/what-are-lasting-consequences-childhood-onset-atopic-dermatitis-</loc><lastmod>2026-06-02T21:00:00Z</lastmod><news:news><news:publication_date>2026-06-02T21:00:00Z</news:publication_date>
        <news:title><![CDATA[What Are the Lasting Consequences of Childhood-Onset Atopic Dermatitis?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/early-introduction-rescue-refeeding-home-oit-pediatric-food-allergy</loc><lastmod>2026-06-02T19:00:00Z</lastmod><news:news><news:publication_date>2026-06-02T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Early Introduction, Rescue Refeeding, and Home OIT: Reframing Pediatric Food Allergy Management]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/ada-scientific-sessions-2026-preview-6-trials-to-know</loc><lastmod>2026-06-02T18:15:00Z</lastmod><news:news><news:publication_date>2026-06-02T18:15:00Z</news:publication_date>
        <news:title><![CDATA[ADA Scientific Sessions 2026 Preview: 6 Trials to Know]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/lorundrostat-lowers-bp-albuminuria-phase-3-ckd-hypertension-analysis</loc><lastmod>2026-06-02T17:29:37.475Z</lastmod><news:news><news:publication_date>2026-06-02T17:29:37.475Z</news:publication_date>
        <news:title><![CDATA[Lorundrostat Lowers BP, Albuminuria in Phase 3 CKD Hypertension Analysis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/how-career-education-opportunities-impacted-atopic-dermatitis-</loc><lastmod>2026-06-02T15:00:00Z</lastmod><news:news><news:publication_date>2026-06-02T15:00:00Z</news:publication_date>
        <news:title><![CDATA[How Are Career and Education Opportunities Impacted by Atopic Dermatitis? ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/fda-crl-ctx-1301-daily-dexmethylphenidate-adhd</loc><lastmod>2026-06-02T14:48:46.984Z</lastmod><news:news><news:publication_date>2026-06-02T14:48:46.984Z</news:publication_date>
        <news:title><![CDATA[FDA Issues CRL for CTx-1301 in ADHD Over CMC Concerns]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/btk-inhibitors-c-kit-agents-remission-csu-pipeline-suggests</loc><lastmod>2026-06-02T14:26:00Z</lastmod><news:news><news:publication_date>2026-06-02T14:26:00Z</news:publication_date>
        <news:title><![CDATA[BTK Inhibitors, C-Kit Agents, and Remission in CSU: What the Pipeline Suggests  ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/afrezza-s-pediatric-approval-and-improving-adolescent-diabetes-care</loc><lastmod>2026-06-01T23:00:00Z</lastmod><news:news><news:publication_date>2026-06-01T23:00:00Z</news:publication_date>
        <news:title><![CDATA[Afrezza’s Pediatric Approval and Improving Adolescent Diabetes Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/what-is-next-ox40-ligand-inhibition-atopic-dermatitis-</loc><lastmod>2026-06-01T21:00:00Z</lastmod><news:news><news:publication_date>2026-06-01T21:00:00Z</news:publication_date>
        <news:title><![CDATA[What Is Next for OX40 Ligand Inhibition in Atopic Dermatitis?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/how-sparsentan-is-reshaping-care-for-patients-with-fsgs-with-george-vasquez-rios-md</loc><lastmod>2026-06-01T20:00:00Z</lastmod><news:news><news:publication_date>2026-06-01T20:00:00Z</news:publication_date>
        <news:title><![CDATA[How Sparsentan is Reshaping Care for Patients With FSGS, With George Vasquez Rios, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/early-allergen-introduction-infants-reducing-food-allergy-risk-without-routine-testing</loc><lastmod>2026-06-01T19:24:00Z</lastmod><news:news><news:publication_date>2026-06-01T19:24:00Z</news:publication_date>
        <news:title><![CDATA[Early Allergen Introduction in Infants: Reducing Food Allergy Risk Without Routine Testing]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/interpreting-sparsentan-proteinuria-egfr-outcomes</loc><lastmod>2026-06-01T17:00:00Z</lastmod><news:news><news:publication_date>2026-06-01T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Interpreting Sparsentan’s Proteinuria Benefits Despite Missed eGFR Outcomes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/beyond-step-up-therapy-biologic-initiation-selection-access-asthma-copd</loc><lastmod>2026-06-01T16:00:52.663Z</lastmod><news:news><news:publication_date>2026-06-01T16:00:52.663Z</news:publication_date>
        <news:title><![CDATA[Beyond Step-Up Therapy: Biologic Initiation, Selection, and Access in Asthma and COPD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/sequencing-therapies-csu-jonathan-bernstein-md</loc><lastmod>2026-06-01T15:37:24.661Z</lastmod><news:news><news:publication_date>2026-06-01T15:37:24.661Z</news:publication_date>
        <news:title><![CDATA[Sequencing Emerging Therapies in CSU, With Jonathan Bernstein, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/discussing-raising-hs-awareness-treatments-with-kiera-booth-md</loc><lastmod>2026-06-01T14:00:50.137Z</lastmod><news:news><news:publication_date>2026-06-01T14:00:50.137Z</news:publication_date>
        <news:title><![CDATA[Discussing Raising HS Awareness and Treatments, With Kiera Booth, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/mavacamten-snda-gets-fda-priority-review-for-adolescent-obstructive-hcm</loc><lastmod>2026-06-01T13:56:00Z</lastmod><news:news><news:publication_date>2026-06-01T13:56:00Z</news:publication_date>
        <news:title><![CDATA[Mavacamten sNDA Gets FDA Priority Review for Adolescent Obstructive HCM]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/fda-accepts-bla-for-povetacicept-in-iga-nephropathy</loc><lastmod>2026-06-01T12:57:00Z</lastmod><news:news><news:publication_date>2026-06-01T12:57:00Z</news:publication_date>
        <news:title><![CDATA[FDA Accepts BLA for Povetacicept in IgA Nephropathy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/how-dermatologists-tailor-sunscreen-counseling-skin-of-color</loc><lastmod>2026-05-31T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-31T19:00:00Z</news:publication_date>
        <news:title><![CDATA[How Dermatologists Can Tailor Sunscreen Counseling for Skin of Color]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/the-hcpfive-top-news-for-healthcare-providers-from-the-week-of-05-24</loc><lastmod>2026-05-30T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-30T19:00:00Z</news:publication_date>
        <news:title><![CDATA[The HCPFive: Top News for Healthcare Providers from the Week of 05/24]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/retatrutide-provides-substantial-weight-loss-patients-with-obesity-or-overweight</loc><lastmod>2026-05-30T14:00:00Z</lastmod><news:news><news:publication_date>2026-05-30T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Retatrutide Provides Substantial Weight Loss in Patients With Obesity or Overweight]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/endotyping-biomarkers-csu-jonathan-bernstein-md</loc><lastmod>2026-05-29T23:04:10.832Z</lastmod><news:news><news:publication_date>2026-05-29T23:04:10.832Z</news:publication_date>
        <news:title><![CDATA[Endotyping & Biomarkers in CSU, With Jonathan Bernstein, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/discussing-zumilokibart-data-atopic-dermatitis-ruth-ann-vleugels-md-mph-mba</loc><lastmod>2026-05-29T21:00:00Z</lastmod><news:news><news:publication_date>2026-05-29T21:00:00Z</news:publication_date>
        <news:title><![CDATA[Discussing Zumilokibart Data in Atopic Dermatitis, With Ruth Ann Vleugels, MD, MPH, MBA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/could-e2f2-offer-precise-anti-remodeling-target-pah-</loc><lastmod>2026-05-29T18:45:51.343Z</lastmod><news:news><news:publication_date>2026-05-29T18:45:51.343Z</news:publication_date>
        <news:title><![CDATA[Could E2F2 Offer a More Precise Anti-Remodeling Target in PAH?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/bepirovirsen-achieves-19-functional-cure-in-chronic-hepatitis-b</loc><lastmod>2026-05-29T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-29T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Bepirovirsen Achieves 19% Functional Cure in Chronic Hepatitis B]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/fda-approves-inhaled-insulin-afrezza-pediatric-patients-diabetes</loc><lastmod>2026-05-29T16:42:00Z</lastmod><news:news><news:publication_date>2026-05-29T16:42:00Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Inhaled Insulin Afrezza for Pediatric Patients With Diabetes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/diabetes-dialogue-fda-approves-afrezza-inhaled-insulin-for-pediatric-patients</loc><lastmod>2026-05-29T16:34:00Z</lastmod><news:news><news:publication_date>2026-05-29T16:34:00Z</news:publication_date>
        <news:title><![CDATA[Diabetes Dialogue: FDA Approves Afrezza Inhaled Insulin for Pediatric Patients]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/first-dual-glucose-ketone-monitor-clearance-europe</loc><lastmod>2026-05-29T16:06:00Z</lastmod><news:news><news:publication_date>2026-05-29T16:06:00Z</news:publication_date>
        <news:title><![CDATA[The World’s First Dual Glucose-Ketone Monitor Receives Clearance in Europe]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/addressing-pediatric-patients-caregivers-fears-dermatology-lisa-swanson-md</loc><lastmod>2026-05-29T14:00:00Z</lastmod><news:news><news:publication_date>2026-05-29T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Addressing Pediatric Patients' and Caregivers' Fears in Dermatology, With Lisa Swanson, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/adherence-persistence-and-long-term-success-in-ascvd-lipid-lowering-therapy</loc><lastmod>2026-05-29T12:05:00Z</lastmod><news:news><news:publication_date>2026-05-29T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Adherence, Persistence, and Long-Term Success in ASCVD Lipid-Lowering Therapy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/safety-tolerability-and-patient-centered-decision-making-in-ascvd-lipid-therapy</loc><lastmod>2026-05-29T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-29T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Safety, Tolerability, and Patient-Centered Decision-Making in ASCVD Lipid Therapy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/what-does-new-phase-3-amlitelimab-data-suggest-atopic-dermatitis-</loc><lastmod>2026-05-28T23:00:00Z</lastmod><news:news><news:publication_date>2026-05-28T23:00:00Z</news:publication_date>
        <news:title><![CDATA[What Does New Phase 3 Amlitelimab Data Suggest for Atopic Dermatitis?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/advancements-roadblocks-cardiovascular-care-women</loc><lastmod>2026-05-28T20:00:00Z</lastmod><news:news><news:publication_date>2026-05-28T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Recent Advancements and Ongoing Roadblocks in Cardiovascular Care for Women]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/efdoralprin-alfa-normalizes-alpha-1-antitrypsin-phase-2-elevaate</loc><lastmod>2026-05-28T19:32:02.783Z</lastmod><news:news><news:publication_date>2026-05-28T19:32:02.783Z</news:publication_date>
        <news:title><![CDATA[Efdoralprin Alfa Normalizes Alpha-1 Antitrypsin Levels in Phase 2 ElevAATe]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/visibility-mentorship-emotional-toll-pediatric-dermatology-lisa-swanson-md</loc><lastmod>2026-05-28T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-28T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Visibility, Mentorship, and the Emotional Toll of Pediatric Dermatology, With Lisa Swanson, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/superlearner-ml-improves-cardiovascular-risk-prediction-in-osa</loc><lastmod>2026-05-28T18:01:08.038Z</lastmod><news:news><news:publication_date>2026-05-28T18:01:08.038Z</news:publication_date>
        <news:title><![CDATA[SuperLearner ML Improves Cardiovascular Risk Prediction in OSA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/diabetes-dialogue-ckm-systems-triple-agonists-sensor-scandal-ahead-of-ada</loc><lastmod>2026-05-28T16:00:00Z</lastmod><news:news><news:publication_date>2026-05-28T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Diabetes Dialogue: CKM Systems, Triple Agonists, and a Sensor Scandal Ahead of ADA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/fda-grants-priority-review-to-saroglitazar-nda-for-primary-biliary-cholangitis</loc><lastmod>2026-05-28T16:00:00Z</lastmod><news:news><news:publication_date>2026-05-28T16:00:00Z</news:publication_date>
        <news:title><![CDATA[FDA Grants Priority Review to Saroglitazar NDA for Primary Biliary Cholangitis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/dupilumab-doubled-remission-odds-type-2-asthma-simon-couillard-md</loc><lastmod>2026-05-28T14:16:00Z</lastmod><news:news><news:publication_date>2026-05-28T14:16:00Z</news:publication_date>
        <news:title><![CDATA[Dupilumab Nearly Doubled Remission Odds in Type 2 Asthma, With Simon Couillard, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/obefazimod-sustains-remission-after-dose-reduction-in-uc-extension-trial</loc><lastmod>2026-05-28T13:42:52.253Z</lastmod><news:news><news:publication_date>2026-05-28T13:42:52.253Z</news:publication_date>
        <news:title><![CDATA[Obefazimod Sustains Remission After Dose Reduction in UC Extension Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/the-future-of-wilson-disease-care-expert-centers-advocacy-and-clinical-hope</loc><lastmod>2026-05-28T12:05:00Z</lastmod><news:news><news:publication_date>2026-05-28T12:05:00Z</news:publication_date>
        <news:title><![CDATA[The Future of Wilson Disease Care: Expert Centers, Advocacy, and Clinical Hope]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/navigating-biologic-therapy-options-in-ibd</loc><lastmod>2026-05-28T12:05:00.000Z</lastmod><news:news><news:publication_date>2026-05-28T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Navigating Biologic Therapy Options in IBD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/diagnosis-and-early-treatment-in-ibd</loc><lastmod>2026-05-28T12:00:00.000Z</lastmod><news:news><news:publication_date>2026-05-28T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Diagnosis and Early Treatment in IBD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/the-multidisciplinary-approach-to-patient-counseling-and-care-transitions-in-wilson-disease</loc><lastmod>2026-05-28T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-28T12:00:00Z</news:publication_date>
        <news:title><![CDATA[The Multidisciplinary Approach to Patient Counseling and Care Transitions in Wilson Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/why-is-sunscreen-gap-significant-dermatology-</loc><lastmod>2026-05-27T21:00:00Z</lastmod><news:news><news:publication_date>2026-05-27T21:00:00Z</news:publication_date>
        <news:title><![CDATA[Why is the 'Sunscreen Gap' Significant in Dermatology?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/sglt2-inhibitors-linked-lower-readmission-risk-copd-hospitalization</loc><lastmod>2026-05-27T19:42:00Z</lastmod><news:news><news:publication_date>2026-05-27T19:42:00Z</news:publication_date>
        <news:title><![CDATA[SGLT2 Inhibitors Linked to Lower Readmission Risk After AE-COPD Hospitalization]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/paths-forward-hypertension-awareness-control-keith-ferdinand-md</loc><lastmod>2026-05-27T17:30:00Z</lastmod><news:news><news:publication_date>2026-05-27T17:30:00Z</news:publication_date>
        <news:title><![CDATA[Paths Forward in Hypertension Awareness and Control, With Keith Ferdinand, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/abcs-in-dermatology-understanding-ox40l-in-atopic-dermatitis</loc><lastmod>2026-05-27T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-27T17:00:00Z</news:publication_date>
        <news:title><![CDATA[ABCs in Dermatology: Understanding OX40L in Atopic Dermatitis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/sotatercept-promise-group-3-chronic-lung-disease-pulmonary-hypertension</loc><lastmod>2026-05-27T15:08:00Z</lastmod><news:news><news:publication_date>2026-05-27T15:08:00Z</news:publication_date>
        <news:title><![CDATA[Sotatercept Shows Promise in Group 3 Chronic Lung Disease Pulmonary Hypertension]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/fda-approves-linaclotide-linzess-for-functional-constipation-in-patients-2-years-and-older</loc><lastmod>2026-05-27T15:01:54.569Z</lastmod><news:news><news:publication_date>2026-05-27T15:01:54.569Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Linaclotide (Linzess) for Functional Constipation in Patients 2 Years And Older]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/apex-positive-16-week-data-released-zumilokibart-atopic-dermatitis</loc><lastmod>2026-05-27T14:13:49.220Z</lastmod><news:news><news:publication_date>2026-05-27T14:13:49.220Z</news:publication_date>
        <news:title><![CDATA[APEX: Positive 16-Week Data Released on Zumilokibart for Atopic Dermatitis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/fda-grants-de-novo-cardiosense-pcwp-software-hfref</loc><lastmod>2026-05-27T13:40:00Z</lastmod><news:news><news:publication_date>2026-05-27T13:40:00Z</news:publication_date>
        <news:title><![CDATA[FDA Grants De Novo Status to Cardiosense PCWP Software for HFrEF]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/roche-launches-liver-disease-panel-an-algorithm-based-tool-for-identifying-and-managing-cld</loc><lastmod>2026-05-27T12:50:52.987Z</lastmod><news:news><news:publication_date>2026-05-27T12:50:52.987Z</news:publication_date>
        <news:title><![CDATA[Roche Launches Liver Disease Panel, An Algorithm-Based Tool for Identifying and Managing CLD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/depression-poor-asthma-control-call-mental-health-attention</loc><lastmod>2026-05-27T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-27T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Depression and Poor Asthma Control Call for Mental Health Attention]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/sunrise-tezepelumab-meaningful-ocs-reduction-severe-asthma-michael-wechsler-md-msc</loc><lastmod>2026-05-26T21:00:00Z</lastmod><news:news><news:publication_date>2026-05-26T21:00:00Z</news:publication_date>
        <news:title><![CDATA[SUNRISE: Tezepelumab Shows Meaningful OCS Reduction in Severe Asthma, With Michael E. Wechsler, MD, MSc]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/higher-resolution-ct-predict-pneumothorax-blvr-isam-albaba-mbbs</loc><lastmod>2026-05-26T19:43:52.861Z</lastmod><news:news><news:publication_date>2026-05-26T19:43:52.861Z</news:publication_date>
        <news:title><![CDATA[Higher-Resolution CT May Predict Pneumothorax After BLVR, With Isam Albaba, MBBS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/proactive-hf-cordella-pa-sensor-improves-hf-status-regardless-of-ef</loc><lastmod>2026-05-26T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-26T19:00:00Z</news:publication_date>
        <news:title><![CDATA[PROACTIVE-HF: Cordella PA Sensor Improves HF Status Regardless of EF]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/greater-steroid-doses-shorter-hospitalization-autoimmune-ild</loc><lastmod>2026-05-26T17:11:00Z</lastmod><news:news><news:publication_date>2026-05-26T17:11:00Z</news:publication_date>
        <news:title><![CDATA[Greater Steroid Doses Linked to Shorter Hospitalization in AE-SARD-ILD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/oral-versus-iv-iron-populations-that-warrant-upfront-escalation-the-implementation-gap-and-always-finding-the-underlying-cause</loc><lastmod>2026-05-12T21:00:57.081Z</lastmod><news:news><news:publication_date>2026-05-26T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Oral Versus IV Iron, Populations That Warrant Upfront Escalation, the Implementation Gap, and Always Finding the Underlying Cause]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/tezepelumab-reduced-severe-asthma-phenotypes-phase-4-passage</loc><lastmod>2026-05-26T15:09:18.367Z</lastmod><news:news><news:publication_date>2026-05-26T15:09:18.367Z</news:publication_date>
        <news:title><![CDATA[Tezepelumab Reduced Severe Asthma Across Phenotypes in Phase 4 PASSAGE]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/skin-of-color-savvy-sunscreen-gap-cancer-prevention-skin-color</loc><lastmod>2026-05-26T15:00:00Z</lastmod><news:news><news:publication_date>2026-05-26T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Skin of Color Savvy: The Sunscreen Gap—Cancer Prevention in Skin of Color]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/hidden-risk-reassessing-long-term-cancer-impact-ct-scans</loc><lastmod>2026-05-26T14:15:39.492Z</lastmod><news:news><news:publication_date>2026-05-26T14:15:39.492Z</news:publication_date>
        <news:title><![CDATA[The Hidden Risk: Reassessing the Long-Term Cancer Impact of CT Scans]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/verve-102-lowers-pcsk9-ldl-c-interim-phase-1b-hypercholesterolemia-data</loc><lastmod>2026-05-26T13:26:00Z</lastmod><news:news><news:publication_date>2026-05-26T13:26:00Z</news:publication_date>
        <news:title><![CDATA[VERVE-102 Lowers PCSK9, LDL-C in Interim Phase 1b Hypercholesterolemia Data]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/intravenous-iron-formulation-selection-patient-counseling-infusion-reactions-and-dosing-principles</loc><lastmod>2026-05-12T21:00:57.081Z</lastmod><news:news><news:publication_date>2026-05-26T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Intravenous Iron — Formulation Selection, Patient Counseling, Infusion Reactions, and Dosing Principles ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/q-a-implications-ixekizumab-tirzepatide-data-psoriasis-psa-mark-lebwohl-md</loc><lastmod>2026-05-25T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-25T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Q&A: Implications of Ixekizumab, Tirzepatide Data for Psoriasis and PsA, With Mark Lebwohl, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/hcpfive-top-news-healthcare-providers-week-of-05-17</loc><lastmod>2026-05-25T00:00:54.990Z</lastmod><news:news><news:publication_date>2026-05-25T00:00:54.990Z</news:publication_date>
        <news:title><![CDATA[The HCPFive: Top News for Healthcare Providers from the Week of 05/17]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/phase-3b-data-ixekizumab-tirzepatide-psoriasis-overweight-mark-lebwohl-md</loc><lastmod>2026-05-24T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-24T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/addressing-the-manifold-barriers-in-hypertension-with-michael-miedema-md</loc><lastmod>2026-05-23T19:00:00Z</lastmod><news:news><news:publication_date>2026-05-23T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Addressing the Manifold Barriers in Hypertension, With Michael Miedema, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/cryobiopsy-outperforms-forceps-transbronchial-lung-biopsy-rct</loc><lastmod>2026-05-23T00:00:00Z</lastmod><news:news><news:publication_date>2026-05-23T00:00:00Z</news:publication_date>
        <news:title><![CDATA[Cryobiopsy Outperforms Forceps in Transbronchial Lung Biopsy in RCT]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/bulevirtide-historic-first-fda-approval-chronic-hepatitis-delta</loc><lastmod>2026-05-22T17:39:26.346Z</lastmod><news:news><news:publication_date>2026-05-22T17:39:26.346Z</news:publication_date>
        <news:title><![CDATA[Bulevirtide Receives Historic First FDA Approval for Chronic Hepatitis Delta]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/secondary-analyses-of-oceanic-stroke-confirm-efficacy-of-asundexian</loc><lastmod>2026-05-22T17:00:00Z</lastmod><news:news><news:publication_date>2026-05-22T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Secondary Analyses of OCEANIC-STROKE Confirm Efficacy of Asundexian]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/significance-new-phase-3-lebrikizumab-trial-nummular-eczema-kilian-eyerich-md-phd</loc><lastmod>2026-05-22T15:00:00Z</lastmod><news:news><news:publication_date>2026-05-22T15:00:00Z</news:publication_date>
        <news:title><![CDATA[Significance of New Phase 3 Lebrikizumab Trial in Nummular Eczema, With Kilian Eyerich, MD, PhD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/advancing-ascvd-management-with-pcsk9-inhibitors</loc><lastmod>2026-05-22T12:05:00Z</lastmod><news:news><news:publication_date>2026-05-22T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Advancing ASCVD Management with PCSK9 Inhibitors]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/the-role-of-non-statin-oral-therapies-in-ascvd-risk-reduction</loc><lastmod>2026-05-22T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-22T12:00:00Z</news:publication_date>
        <news:title><![CDATA[The Role of Non-Statin Oral Therapies in ASCVD Risk Reduction]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/ai-model-outperforms-standard-echocardiograms-heart-disease-detection</loc><lastmod>2026-05-21T23:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T23:00:00Z</news:publication_date>
        <news:title><![CDATA[New AI Model Outperforms Standard Echocardiograms in Heart Disease Detection]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/phase-3-lumine-trial-assess-lebrikizumab-nummular-eczema-kilian-eyerich-md-phd</loc><lastmod>2026-05-21T21:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T21:00:00Z</news:publication_date>
        <news:title><![CDATA[Phase 3 LumiNE Trial to Assess Lebrikizumab in Nummular Eczema, With Kilian Eyerich, MD, PhD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/hfmref-as-a-unique-phenotype-of-heart-failure-with-jane-wilcox-md-msc</loc><lastmod>2026-05-21T17:20:00Z</lastmod><news:news><news:publication_date>2026-05-21T17:20:00Z</news:publication_date>
        <news:title><![CDATA[HFmrEF as a Unique Phenotype of Heart Failure, With Jane Wilcox, MD, MSc]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/fda-grants-priority-review-to-finerenone-for-type-1-diabetes-and-ckd</loc><lastmod>2026-05-21T14:50:00Z</lastmod><news:news><news:publication_date>2026-05-21T14:50:00Z</news:publication_date>
        <news:title><![CDATA[FDA Grants Priority Review to Finerenone for Type 1 Diabetes and CKD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/retatrutide-weight-loss-endpoints-phase-3-obesity-trial</loc><lastmod>2026-05-21T14:15:00Z</lastmod><news:news><news:publication_date>2026-05-21T14:15:00Z</news:publication_date>
        <news:title><![CDATA[Retatrutide Meets Weight Loss Endpoints in Phase 3 Obesity Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/mixed-aerify-data-delay-itepekimab-approval-pathway-copd-klaus-rabe-md-phd</loc><lastmod>2026-05-21T14:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Mixed AERIFY Data May Delay Itepekimab Approval Pathway in COPD, With Klaus F. Rabe, MD, PhD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/real-world-evidence-and-strategies-for-long-term-adherence-in-wilson-disease</loc><lastmod>2026-05-21T12:05:00Z</lastmod><news:news><news:publication_date>2026-05-21T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Real-World Evidence and Strategies for Long-Term Adherence in Wilson Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/gene-therapy-as-an-emerging-treatment-approach-in-wilson-disease</loc><lastmod>2026-05-21T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Gene Therapy as an Emerging Treatment Approach in Wilson Disease]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/closing-the-loop-key-recommendations-and-future-directions-for-epi</loc><lastmod>2026-05-21T12:00:00Z</lastmod><news:news><news:publication_date>2026-05-21T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Closing the Loop: Key Recommendations and Future Directions for EPI]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/aerify-phase-3-data-reveal-challenges-potential-itepekimab-copd</loc><lastmod>2026-05-20T23:00:00Z</lastmod><news:news><news:publication_date>2026-05-20T23:00:00Z</news:publication_date>
        <news:title><![CDATA[AERIFY: Phase 3 Data Reveal Challenges, Potential of Itepekimab in COPD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/rapid-evolution-glp-1s-therapeutics-ada-2026</loc><lastmod>2026-05-20T21:00:00Z</lastmod><news:news><news:publication_date>2026-05-20T21:00:00Z</news:publication_date>
        <news:title><![CDATA[Rapid Evolution in GLP-1s and Therapeutics at ADA 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/not-everything-that-wheezes-asthma-comorbidities-mimickers-right-time-to-escalate</loc><lastmod>2026-05-20T20:23:21.548Z</lastmod><news:news><news:publication_date>2026-05-20T20:23:21.548Z</news:publication_date>
        <news:title><![CDATA[Not Everything That Wheezes Is Asthma: Comorbidities, Mimickers, and the Right Time to Escalate]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/plaque-imaging-transform-myocardial-infarction</loc><lastmod>2026-05-20T16:00:00Z</lastmod><news:news><news:publication_date>2026-05-20T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Plaque Imaging and the TRANSFORM Trial in Myocardial Infarction]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/ralinepag-55-risk-reduction-pah-vallerie-mclaughlin-md</loc><lastmod>2026-05-20T15:23:26.723Z</lastmod><news:news><news:publication_date>2026-05-20T15:23:26.723Z</news:publication_date>
        <news:title><![CDATA[Ralinepag Achieves 55% Risk Reduction in PAH, With Vallerie McLaughlin, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.hcplive.com/view/what-phase-3-ad109-data-mean-sleep-apnea-patrick-john-strollo-md</loc><lastmod>2026-05-20T14:00:00Z</lastmod><news:news><news:publication_date>2026-05-20T14:00:00Z</news:publication_date>
        <news:title><![CDATA[What the Phase 3 AD109 Data Mean for Sleep Apnea, With Patrick John Strollo, MD ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url></urlset>